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! Intrabodies against heterochromatin protein 1 β (HP1β) inhibit its trafﬁc to the nucleus.
! Anti-HP1β intrabodies sequester HP1β in cytoplasmic aggregates.
! Anti-HP1β scFv causes co-aggregation of LBR and H3–H4 histones in the cytoplasm.
! Methylated histone H3 at K9 (Me9H3) is not affected by anti-HP1β scFv expression.
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a b s t r a c t
Diverting a Q2protein from its intracellular location is a unique property of intrabodies. To interfere with the
intracellular trafﬁc of heterochromatin protein 1β (HP1β) in living cells, we have generated a cytoplasmic
targeted anti-HP1β intrabody, speciﬁcally directed against the C-terminal portion of the molecule. HP1β
is a conserved component of mouse and human constitutive heterochromatin involved in diverse nuclear
functions including gene silencing, DNA repair and nuclear membrane assembly. We found that the anti-
HP1β intrabody sequesters HP1β into cytoplasmic aggregates, inhibiting its trafﬁc to the nucleus. Lamin
B receptor (LBR) and a subset of core histones (H3/H4) are also speciﬁcally co-sequestered in the cyto-
plasm of anti-HP1β intrabody-expressing cells. Methylated histone H3 at K9 (Me9H3), a marker of
constitutive heterochromatin, is not affected by the anti-HP1β intrabody expression. Hyper-acetylating
conditions completely dislodge H3 from HP1β:LBR containing aggregates. The expression of anti-HP1β
scFv fragments induces apoptosis, associated with an alteration of nuclear morphology. Both these
phenotypes are speciﬁcally rescued either by overexpression of recombinant full length HP1β or by HP1β
mutant containing the chromoshadow domain, but not by recombinant LBR protein. The HP1β-chro-
modomain mutant, on the other hand, does not rescue the phenotypes, but does compete with LBR for
binding to HP1β. These ﬁndings provide new insights into the mode of action of cytoplasmic-targeted
intrabodies and the interaction between HP1β and its binding partners involved in peripheral hetero-
chromatin organisation.
& 2015 Published by Elsevier Inc.
1. Introduction
The gene-based approach of intracellular antibodies (in-
trabodies) relies on the manipulation and expression of re-
combinant antibodies in different intracellular compartments to
ablate or modulate the function of target molecules [1,2]. In-
trabodies can hamper the function of the target antigen by direct
binding to the functional domain [3] or by diverting the antigen to
a different subcellular location. Examples of diverting include cy-
toplasm [4], nucleus [5,6], endoplasmic reticulum [7] and the
proteasome degradation pathway [8,9]. These molecules have
found applications as therapeutics in infectious diseases, in cancer
and in neurodegenerative disorders [2,10].
We have previously demonstrated that nuclear and cyto-
plasmic targeting of intrabodies against different epitopes of the
chromodomain (CD) of heterochromatin proteins 1 (HP1) in
mammalian cells induces cell death [11]. HP1 proteins were ori-
ginally identiﬁed as crucial factors involved in heterochromatin
formation and gene silencing [12], but subsequent studies re-
vealed that these proteins have additional nuclear functions in-
cluding chromosome segregation, telomere maintenance, DNA
repair, transcriptional activation and sister chromatid cohesion [13
and references herein]. In mammals, three subtypes of HP1 have
been identiﬁed: HP1α, HP1β and HP1γ [14]. HP1 proteins consist
of two highly conserved regions, the N-terminal chromodomain
(CD) and the C-terminal chromoshadow domain (CSD), linked by
the “hinge” ﬂexible sequence [15]. The HP1 CD binds to methy-
lated lysine 9 of histone H3 [16,17], a property consistent with the
histone-code hypothesis [18]. The CSD is required for homo- and
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hetero-dimerisation of HP1 proteins and interaction with speciﬁc
protein ligands such as CAF-1 subunit p150, nuclear auto-antigen
SP100, Su(var)3–7 and LBR via the PXVXL motif [19,20]. It is also
involved in the recruitment of HP1 proteins to DNA damage sites
under different stimuli [21]. The less conserved hinge region is
implicated in binding of different molecular partners including the
inner centromere protein (INCENP), histone deacetylases, RNA and
DNA [22–25].
Mammalian HP1 associate with components of the nuclear
envelope (NE) and, in particular, with the lamin B receptor (LBR)
[26,27]. LBR is a type II inner nuclear transmembrane protein
whose N-terminus faces the nucleoplasm [28]. This protruding
domain binds in vitro to B-type lamins [26] and to HP1. Moreover,
microinjection of mouse recombinant HP1 into living cells have
shown a transient interaction of HP1 with the nuclear envelope
and dominant negative mutants of HP1 inhibit nuclear reassembly
in an in vitro assay [29]. Molecular characterisation of the HP1-NE
interaction has revealed that HP1 proteins form, in vitro, a tight
complex with two core histones (H3/H4) and LBR [30,31]. These
interactions have been correlated with a possible role of HP1 in
peripheral heterochromatin organisation and in regulating nuclear
membrane re-assembly at the end of the mitosis [30,31]. However,
a direct involvement of HP1 in the process of NE formation in
mammalian cells has not been yet demonstrated in vivo.
Despite their structural similarity and high sequence homology,
HP1 isotypes segregate into distinct nuclear domains [32] and
display diverse and multiple functions [13]. Thus, mice deﬁcient
for each HP1 isotype manifest different phenotypes [33,34]. In
particular, HP1β deﬁcient mice show perinatal lethality associated
with defective neuromuscular and cerebral cortex development,
and genomic instability, indicating that HP1β is essential for or-
ganismal survival and that HP1 proteins are not functionally re-
dundant [33]. However, mice expressing only 10% of HP1β protein
levels are indistinguishable from wild-type littermates [35], sug-
gesting that the amount of HP1β required for survival is small [36].
Consistent with these results, knockdown of HP1β by speciﬁc RNAi
in different cell types neither induces cell death nor alters cell
cycle progression [37,38].
Here we aimed at speciﬁcally interfering with HP1β by intra-
body-mediated retargeting of HP1β from its nuclear physiological
location to the cytoplasm. To this aim, we have cloned a scFv
fragment speciﬁcally directed against the CSD domain of HP1β
into a vector optimised for cytoplasmic expression.
2. Materials and methods
2.1. Engineering of the 353-scFv fragment
Hybridoma V regions of the rat monoclonal antibody MAC 353
[39], directed against the C-terminal sequence of the HP1β have
been cloned using a phage display system as previously described
[40]. Since sequences of non-functionally rearranged variable light
(VL) regions (pseudogenes) were obtained by PCR of the MAC 353
hybridoma cDNA, we used an antisense directed RnaseH digestion
of the myeloma derived VL pseudogene mRNA, as described [41].
The following antisense oligonucleotide directed against the
pseudogene CDR 3 region of the myeloma light chain was de-
signed: 5′ TGG GCA TCT ACT AGG CAA TCT GGT 3′.Q3 Brieﬂy, mRNA
obtained from 5#105 hybridoma cells was suspended in 20 μl
1 mM EDTA pH 7.4, incubated 10 min at 70 °C for breakage the
secondary structure and digested (30 min at 37 °C) with 1.6 U of
RnaseH (Promega) in the presence of 120 pmol of antisense oli-
gonucleotide. The remaining non digested VL region was PCR
ampliﬁed and cloned into pDAN plasmid [42]. The variable heavy
(VH) gene was PCR ampliﬁed using selected oligos [43].
2.2. ELISA assay
Supernatants containing the scFv-expressing phages were
analysed in a phage-enzyme-linked immunosorbent assay (phage-
ELISA) for binding to coated recombinant HP1β and lysozyme
(Sigma) as a negative control. Positive clones were further ana-
lysed by ﬁngerprinting and sequencing. Selected anti-HP1β scFvs
and the anti-lysozyme scFv D1.3 [44] were expressed in E. coli
HB2151 non-suppressor strain and puriﬁed by afﬁnity chromato-
graphy using Ni-NTA agarose (Quiagen). ELISA assay was carried
out by coating the plate with 1 μg of recombinant HP1α, HP1β,
HP1γ GST-fusion proteins and 300 μg of lysozyme, as described
[11].
2.3. DNA constructs
For the expression in mammalian cells, the anti-HP1β 353-scFv
was subcloned into the NcoI/NotI sites of pscFvexpress-cyt and
pscFvexpress-nuc [45]. These vectors direct the expression of the
scFv fragments under the transcriptional control of EF-BOS
(elongation factor 1A) promoter. For PCR ampliﬁcation of anti-
HP1β scFv fragment from the bacterial pDAN-scFv vector, the
following degenerate primers were designed: 5′-CTTGCCATGG-
GATTGTTATTACTC-3′ and 5′-TTTAGCGGCCGCTGGGATTGGTTT-3′.
The pscFvexp-cyt R4 (anti-βgal), which was derived from pPM163-
R4 (kindly provided by P. Martineau) and pscFvexp-cyt αD11 were
subcloned as described previously [11]. HP1 (α, β and γ) were
epitope-tagged in an expression vector by sub-cloning the HP1α/
β/γ open reading frames into pFLAG-CMV-1 (Clontech). GFP-tag-
ged HP1β mutants that contain the CSD (GFP-CSD), the CD (GFP-
CD) and the hinge region alone (GFP-HP1h) were constructed as
described [46].
2.4. Antibodies
The detection of scFv fragments was carried out using the
mouse anti-myc IgG 9E10 (Invitrogen) and the afﬁnity-puriﬁed
rabbit anti-myc IgG (Santa-Cruz). MAC 353 [39] and a polyclonal
rabbit antiserum (Upstate) were used to identify HP1β. HP1α was
detected with a polyclonal rabbit antiserum (M235) [39], HP1γ by
the rat anti-HP1γ IgM (MAC 385) [47], methylated histone H3 in
lysine 9 (Me9H3) with a rabbit anti-Me9H3 IgG [48], Suvar39h1
with a polyclonal rabbit anti-Suvar39h1 (Santa Cruz) and LBR with
afﬁnity-puriﬁed rabbit anti-LBR antibodies. All anti-histones anti-
bodies were purchased from Cell Signalling Technology. Flag-tag-
ged recombinant proteins were identiﬁed by mouse anti-Flag IgG
(Sigma).
2.5. Cell lines, transfection, drug treatments and western blotting
NIH-3T3 ﬁbroblasts and HeLa cells were grown in DMEM
medium (Euroclone) supplemented with 10% foetal bovine serum
(FBS). Cells were grown to 85% conﬂuency and transiently trans-
fected with Superfect (Qiagen) following the manufacturer's in-
structions. Cells were harvested and analysed 24–48 h after
transfection. For rescue experiments, cells were co-transfected
with 1 μg of cyt-353 intrabody plasmid and increasing amount of
constructs (0.25, 0.5 and 1 μg) encoding for HP1α, β and γ, LBR
and GFP-tagged HP1 mutants containing the CSD (GFP-CSD), the
CD (GFP-CD) or the hinge region (GFP-h). For drug treatments, just
after transfection, cells were cultured for 16 h in complete medium
containing 200 ng/ml TSA (Sigma) and 1 or 5 mM Na Butyrate
(Sigma).
Extraction of proteins from transfected cells and Western
blotting were performed as previously reported [11]. Horseradish
peroxidase-linked anti-mouse IgG (Amersham Pharmacia Biotech),
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anti-rabbit IgG (Amersham Pharmacia Biotech) and anti-rat IgG
(Pierce) were used as secondary antibodies.
2.6. Preparation of nuclear and cytoplasmic fractions
3#106 transfected cells were washed twice in PBS, scraped and
collected. The nuclear and cytoplasmic fractions were prepared by
resuspending cells in 0,3 ml hypotonic isolation buffer (IB)
(10 mMTris–HCl pH 7.6, 10 mMNaCl, 1.5 mM MgCl2, protease in-
hibitor cocktail [1:1000] (Calbiochem) and 0.1 mM phenyl-methyl-
sulfonyl-ﬂuoride (PMSF)). Cells were passed through an ice-cold
cylinder cell homogenizer and nuclei isolated by centrifuging at
4 °C for 15 min at 290# g. Nuclear pellet was washed twice with
0.3 ml of IB, incubated for 30 min on ice in modiﬁed IB with 1%
Triton X-100 and centrifuged at 12,000# g for 15 min to separate
the soluble and the insoluble nuclear fractions. The cytoplasmic
supernatant, after two subsequent centrifugations for clearing
from cell debris, was detergent extracted by adding 0,5% Non-
idetP40 (Sigma) for 30 min on ice and centrifuged twice
(12,000# g at 4 °C for 15 min) to separate the soluble and in-
soluble fractions. The cytoplasmic pellet was washed twice in
NP40 enriched IB buffer by subsequent centrifugations at
12,000# g for 15 min. Soluble (S) and insoluble (I) proteins from
nuclei and cytoplasm were separated on SDS-PAGE and analysed
by Western blot.
2.7. Immunoﬂuorescence
Immunoﬂuorescence, including in situ identiﬁcation of apop-
totic cells, was carried out as previously described [11]. For LBR
detection, cells were ﬁxed and permeabilised with cold methanol
at $20 °C for 7 min, rinsed in PBS and incubated over night at 4 °C
with the primary antibody. Cy™2-conjugated*AfﬁniPure Donkey
anti-rabbit IgG, Cy™2-conjugated AfﬁniPure rabbit anti-goat IgG
(Jackson Immunoresearch) and Texas Red anti-mouse IgG (Cal-
biochem) were used as secondary antibodies. Hoechst 33342 dye
was used at 300 ng/ml. Samples were examined with a Leica
ﬂuorescence microscope and CCD camera, equipped with oil
immersion lens.
Confocal images were acquired by using PCM-2000 Confocal
Microscope (Nikon) and processed by the PCM-2000 Software
(Nikon).
2.8. Statistical data analysis
Data are reported as mean7SEM. Results were analysed using
one-way ANOVA and were considered statistically signiﬁcant
when p valueo0.05.
3. Results
3.1. Anti-HP1β intrabodies speciﬁcally sequester HP1β in the cyto-
plasm of mammalian cells
We used the phage display system to clone the V regions of
MAC 353, an anti-HP1β monoclonal antibody, speciﬁcally directed
against the C-terminal portion of the protein, in a scFv intrabody
format. MAC 353 is a rat IgG and speciﬁcally recognises both hu-
man and mouse HP1β [39]. Fig. 1A shows the aminoacid sequence
of MAC 353 scFv fragment as deduced from the nucleotide se-
quence. Recombinant anti-HP1β scFv was expressed in bacteria,
puriﬁed and characterized for its binding speciﬁcity by ELISA. As
shown in Fig. 1B, the scFv maintains the immunogenic properties
of the original monoclonal antibody MAC 353.
In order to retarget the nuclear protein HP1β to the cytoplasm,
the 353 scFv was subcloned into vectors optimised for cytoplasmic
expression in mammalian cells (cyt-353 scFv/intrabody) [40].
Myc-tagged cyt-353 anti-HP1β scFv was transiently transfected in
NIH 3T3 cells and analysed by Western blot. Analysis of soluble
and insoluble proteins extracted from transfected cells shows that
the cyt-353 scFv fragment is insoluble and Triton-resistant
(Fig. 1C). Thus, a single immunoreactive band of the expected size
is present in the insoluble fraction (lane 6). The expression level of
the cyt-353 scFv is comparable to that found for other insoluble
scFvs that we have used as controls, as the anti-NGF scFv αD11
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Fig. 1. Amino-acid sequence and expression of anti-HP1β 353 scFv in E. coli and in mammalian cells. (A) The deduced amino-acid sequence of the VK and VH variable regions
assembled in a scFv format is shown. Complementary determining regions (CDRs), the linker peptide and the myc-tag are boxed. (B) ELISA assay to measure and compare the
binding activity of puriﬁed 353 scFv fragment and the parental Ig. HP1β-GST (black columns), HP1γ-GST (light columns) and lysozyme (squared columns) were used for
coating. As a negative control, a puriﬁed anti-lysozyme D1.3 scFv fragment was used. Values obtained by coating the wells with GST alone have been subtracted. (C) Western
Blot analysis of soluble (S) and insoluble (I) proteins extracted from NIH 3T3 cells transfected with αD11 (lanes 1 and 2), R4 (lanes 3 and 4) and 353 (lanes 5 and 6)
intrabodies. ScFv fragments were detected with Mab anti-Myc 9E10. Differences in electrophoretic mobility between the scFvs are due to their respective primary sequences.
Molecular weight markers (in kDa) are shown on the left.
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(lane 2). The mostly soluble anti-βGal scFv R4 is more efﬁciently
expressed and only a minor amount of R4 intrabody is detected in
the insoluble fraction (lanes 3 and 4). It is worth noting that the
molecular weight of cyt-353 intrabody is lower compared to αD11
and R4 due to differences in primary sequence length (28 kD vs
32 kD).
To test whether the cyt-353 scFv speciﬁcally interacts with
HP1β in the cytoplasm of living cells, we co-transfected myc-tag-
ged cyt-353 intrabody and recombinant Flag-tagged HP1β into
NIH 3T3 cells and undertook double immunoﬂuorescence analysis.
Fig. 2A shows the staining using anti-Myc antibodies to detect scFv
fragments (panels B and F) and anti-Flag antibodies to detect HP1β
(panels C and G). Merged images are shown in panels D and H. The
intracellular localisation of the cyt-353 intrabody was studied by
confocal analysis. As shown in Fig. 2A (panel B) and Fig. 2B (panels
B, F and J) the myc-tagged cyt-353 intrabody is highly expressed
and localizes in the cytoplasm of transfected cells. In most cells the
signal is condensed in the perinuclear region or in large cyto-
plasmic aggregates (see arrows in panels B). In 20–30% of cells the
staining is more reticular and diffusely widespread in the cyto-
plasm (see panel J).
HP1β distribution is altered by the cyt-353 intrabody. As shown
in the merged image, anti-HP1β intrabody co-localises with HP1β
in the cytoplasm (panel D). Intracellular expression of the control
cytoplasmic scFv fragment (R4-anti-βGal) (panel F) does not in-
ﬂuence the nuclear intracellular localisation of HP1β (panels G and
H).
To investigate the speciﬁcity of retargeting, we then in-
vestigated the effect of cyt-353 scFv intrabody on the localisation
of Flag-tagged HP1α and γ, the other two isoforms of HP1 (Fig. 2B).
HP1α is partly diverted to the cytoplasm (panel C) and delocalizes
from its heterochromatic localisation only in a small number of
cells (∼10%). Where delocalisation of HP1α takes place, it accu-
mulates around the nuclear envelope or in smaller deﬁned peri-
nuclear regions (panels C and G). In these regions there is only a
partial co-localisation between cyt-353 scFv and HP1α (merged
images, panels D and H). In contrast, the distribution pattern of
HP1γ does not change in cells expressing the intracellular cyt-353
scFv (Fig. 2B, panels K and L). Expression of the control cyto-
plasmic R4 intrabody does not affect intracellular distribution of
HP1α and HP1γ molecules. It is worth noting that the distribution
of endogenous HP1α and γ in cyt-353 scFv expressing cells par-
allels the results obtained with Flag-tagged recombinant con-
structs (Fig. 5B and data not shown).
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
Fig. 2. Co-localisation analysis of cyt-353 scFv with HP1β, HP1α and HP1γ. (A) Cells were co-transfected with scFv fragments and recombinant HP1β. The intracellular
distribution of scFvs was determined using rabbit anti-Myc antibodies (panels B and F) and HP1β by mouse anti-Flag antibodies (panels C and G). Panels D and H represent
the merged images. Panels A and E depict nuclei stained with Hoechst 33342. (B) Immunoﬂuorescence analysis of NIH 3T3 cells co-transfected with cyt-353 scFv fragment
and the recombinant HP1α and HP1γ proteins. Panels C and G represent the distribution of Flag-tagged HP1α and panel K that of Flag-tagged HP1γ. Panels B, F and J represent
the distribution of 353 intrabodies. Panels A, E and I depict nuclei stained with Hoechst 33342 and panels D, H and L are the merged images. Bar, 5 μm.
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3.2. Intrabody-mediated re-targeting of HP1β causes co-aggregation
of HP1β with LBR and H3–H4 histones in the cytoplasm
Several studies have highlighted the importance of the asso-
ciation of the HP1 proteins with components of the nuclear en-
velope (NE) and, in particular, with LBR, a major constituent of the
inner nuclear membrane [26,29]. LBR associates with HP1 proteins
via histones H3/H4 [30], although other studies showed a direct
binding of LBR to HP1 [26,27].
To test whether diversion of HP1β to the cytoplasm by the
intrabody also affects endogenous LBR localisation, NIH 3T3 cells
were transfected with cyt-353 or the control αD11 scFvs, and
analysed by double immunoﬂuorescence with anti-LBR (Fig. 3,
panels B, F and J) and anti-myc antibodies (Fig. 3, panels C, G and
K). Remarkably, in cyt-353 scFv transfected cells, LBR was pre-
dominantly found in the cytoplasm (panel B) or in large cyto-
plasmic aggregates (panel F), where it co-localises with the 353
intrabody (merged images panels D and H). In cells expressing the
control αD11 scFv, LBR maintains its typical nuclear localisation, as
in non-transfected cells (panel J).
We then studied the distribution of endogenous histones H3
and H4 in cyt-353 scFv transfected cells. Fig. 4A shows the results
of a double staining experiment performed on cells transfected
with the anti-HP1β intrabody (panels C, G and K) and cells
transfected with the control αD11 scFv (panel O). Both intrabodies
mostly localise in the cytoplasm. We ﬁnd that the expression of
cyt-353 scFv intrabody results in a dramatic altered distribution of
histone H3 (panel B) and histone H4 (panel F) that are found in the
cytoplasm of all transfected cells. A strong co-localisation with cyt-
353 intrabody is evident in the merged images (panels D and H
respectively). We never observed changes in the intracellular
distribution of histone H2A (panel J), indicating a speciﬁc inter-
action between HP1β and H3/H4 histones. Interestingly, en-
dogenous methylated histone H3 at K9 (Me9H3) (Fig. 4B, panel B),
which is a marker of constitutive heterochromatin, is not affected
by cyt-353 intrabody and presents its typical nuclear localisation.
The expression of the control αD11 scFv (Fig. 4A, panel O) does not
affect the distribution of H3 (panel N), as well as Me9H3, H4 and
H2A histones and Suvar39h1 (not shown).
It is worth noting that a much higher ﬂuorescence signal of LBR
(Fig. 3, panels B and F), H3 and H4 (Fig. 4A, panels B and F) is
evident in cyt-353 scFv transfected cells compared with cells
transfected with control scFvs (Fig. 3, panel J and Fig. 4A, panel N).
This ﬁnding may suggest inhibition of degradation when these
proteins aggregate in the cytoplasm [8]. The absence of en-
dogenous nuclear staining of histones H3 and H4 in the nucleus in
353 intrabody expressing cells is due to the fact that to acquire
images of cells harbouring aggregates, a short exposure time is
necessary to avoid overexposure of the images, drawing the H3
and H4 nuclear signals below the detection limit in Fig. 4B and F.
Since it has been reported that the interaction of core histones
with HP1 and LBR are regulated by acetylation [29,30], we ana-
lysed the distribution of H3 in cyt-353 scFv transfected cells
treated with different concentration of two deacetylase inhibitors,
TSA and Na butyrate [49]. As shown in Fig. 4C, after treatment
with 5 mM Na butyrate, H3 histone (panel B) is conﬁned in the
nucleus of cyt-353 scFv transfected cells (as in non-transfected
cells), indicating that 353-scFv:HP1β:H3 association in the cyto-
plasm is abolished under hyper-acetylating conditions. On the
contrary, the cytoplasmic localisation of HP1β and LBR in cyt-353
scFv transfected cells was not affected by treatment with deace-
tylase inhibitors (not shown).
We further analysed the biochemical features of cytoplasmic
aggregates detected in cyt-353 scFv expressing cells. We fractio-
nated NIH 3T3 transfected cells by separating nuclear and cyto-
plasmic fractions in the absence of detergent. Subsequently, these
two fractions were detergent-extracted and centrifuged to isolate
soluble and insoluble pools and analysed by Western blot. We
examined the distribution of endogenous HP1β, LBR, H3, Me9H3,
H4, H2A histones and the histone H3 methyl-transferase Su-
var39h1 in the four separated pools derived from intrabody-
transfected and non-transfected cells. In non-transfected cells
(Fig. 5 A) HP1β is mostly in the nucleus, both in the soluble and
insoluble fractions (lanes 1 and 2) although a consistent amount is
also present in the detergent soluble cytoplasmic fraction (lane 3).
LBR, a membrane protein, is completely detergent extractable in
our experimental conditions and partitioned between the soluble
nuclear and cytoplasmic fractions (lanes 1 and 3). Histones H3,
Me9H3, H4, and H2A are present, as expected, only in nuclear
pellets, highly enriched in chromatin (lane 2). Suvar39h1 dis-
tributes mostly in the nucleus (lanes 1 and 2) and, as HP1β, is also
found in the detergent soluble cytoplasmic fraction (lane 3). Im-
portantly, none of these molecules is found in the cytoplasmic
detergent insoluble fraction (Fig. 5A, lane 4).
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Fig. 3. Co-localisation analysis of cyt-353 scFv with LBR. NIH 3T3 cells, transfected with cyt-353 and αD11 scFv fragments, were double stained with Mab 9E10 IgG (panels C,
G, and K) and with rabbit anti-LBR IgG (panels B, F and J). Merged images are shown in panels D, H and L. Panels A, E and I depict nuclei stained with Hoechst 33342. Bar,
5 μm in panels A–D. Bar, 10 μm in panels E–L.
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To investigate the ability of intrabody-mediated diversion of
HP1β, LBR, H3, Me9H3, H4, H2A histones and the histone H3
methyl-transferase Suvar39h1 molecules into cytoplasmic ag-
gregates, we examined the partitioning of the nuclear and cyto-
plasmic insoluble fractions. A consistent amount of endogenous
HP1β is present in the cytoplasmic insoluble pool in cyt-353 scFv
transfected cells (Fig. 5B, compare lane 6 with lanes 2 and 4). LBR
protein is also in the cytoplasmic insoluble fraction (lane 6). Since
LBR is detergent soluble in non-transfected cells (Fig. 5A, lanes
1 and 3), the shift of this molecule towards the insoluble pool is
particularly salient. The same shift is also detectable for H3 and H4
histones, which are present in the insoluble cytoplasmic fraction
only in cyt-353 scFv transfected cells (Fig. 5B, lane 6). It is worth
noting that in cyt-353 scFv transfected cells there is no change in
the distribution of H2A, Me9H3 and Suvar39h1.
As described in Fig. 4C, panel B, hyper-acetylated histone H3
does not interact with HP1β in the cytoplasm. We, therefore,
wanted to verify whether deacetylase inhibitors could affect the
partitioning of H3 in nuclear and cytoplasmic insoluble fractions.
We examined, by Western blot, H3 distribution in cyt-353 scFv
transfected cells treated with different concentration of TSA and
Na butyrate. Both inhibitors were equally effective. As shown in
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Fig. 4. Co-localisation analysis of cyt-353 scFv with H3, H4, H2A, Me9H3 and acetylated H3 histones. (A) Double immuﬂuorescence analysis with rabbit anti-histone H3
(panels B and N), rabbit anti-histone H4 (panel F), rabbit anti-histone H2A (panel J) and Mab anti-myc 9E10 IgG (panels C, G, K, and O) of cells expressing cyt-353 and αD11
scFv fragments as indicated. (B) NIH-3T3 cells transiently transfected with cyt-353 scFv fragment and stained with rabbit anti-Me9H3 IgG (panel B) and with Mab anti-myc
9E10 IgG (panel C). (C) Double immunoﬂuorescence analysis of cyt-353 scFv transfected cells treated with 5 mM Na-butyrate and stained with rabbit anti-histone H3 (panel
B) and Mab anti-myc 9E10 IgG (panel C). Panels A, E, I, and M in (A), and A in (B) and (C) depict nuclei stained with Hoechst 33342 and panels D, H, L, and P in (A), and D in (B)
and (C) represent the merged images. Bar, 5 μm.
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Fig. 5C, the presence of 1 mM Na butyrate (lanes 3 and 4), reduces
the amount of H3 present in the cytoplasmic insoluble fraction
and 5 mM Na butyrate (lanes 5 and 6) completely abolishes the
presence of histone H3 in the cytoplasmic insoluble fraction.
3.3. Altered nuclear morphology and apoptosis in cyt-353 intrabody
expressing cells
Immunoﬂuorescence analysis of transfected NIH 3T3 cells re-
vealed that cyt-353 scFv alters nuclear morphology. To explore this
phenomenon in more detail, we analysed cyt-353 scFv and R4-
scFv expressing cells by immunoﬂuorescence with anti-myc anti-
bodies and counterstaining with Hoechst 33342, 24 h after trans-
fection. As shown in Fig. 6A many nuclei of cyt-353 intrabody-
expressing cells have an irregular shape consisting of invagina-
tions of the nuclear envelope (see arrows in panels A and D). By
counting Annexin V positive cells and condensed/fragmented
nuclei stained with Hoechst 33342-positive cells, we found a cyt-
353 intrabody dose-dependant apoptotic effect (from 0.5 to 2 μg of
DNA plasmid) with a peak of 60–65% of transfected cells under-
going apoptosis at the highest amount of DNA plasmid (Fig. 6B).
Similar results were observed 48 h after transfection (6872%
apoptotic cells, not shown). Parallel experiments in HeLa cells
conﬁrmed the toxicity of cyt-353 intrabody that leads to 5872%
of apoptotic cells by using 2 μg of DNA plasmid (not shown). It is
worth noting that in the same experimental conditions, the con-
trol R4 intrabody does not induce apoptosis or altered nuclear
morphology (Fig. 6B and Fig. 2A, panel E).
3.4. Overexpression of HP1β rescues altered nuclear morphology and
apoptosis
HP1 isoforms exhibit differential patterns of subnuclear loca-
lisation [32], suggesting that, despite their sequence similarities,
HP1α, β and γ interact with chromatin and NE components in
different ways. Notwithstanding this fact, the possibility of re-
dundancy in function between the three isoforms is still an open
question. To examine this possibility, we co-transfected NIH 3T3
cells with increasing amounts of DNA plasmids encoding re-
combinant HP1α, β and γ and constant amount of cyt-353 scFv
(ratios HP1s/scFv1:4; 1:2; 1:1) and inspected the effect of their
overexpression on nuclear morphology and apoptosis. Re-
markably, the ectopic expression of mouse recombinant HP1β
results in an almost complete dose-dependant rescue of the cyt-
353 scFv-induced phenotype (apoptosis/altered nuclear morphol-
ogy was reduced from 60% to 6–8%) (Fig. 6C). Expression of re-
combinant HP1α leads to a 20% rescue of the altered nuclear
morphology and of the apoptotic phenotype at the ratio 1:1. On
the contrary, no signiﬁcant rescue is observed upon expression of
recombinant HP1γ. It is worth noting that recombinant HP1α, β
and γ are expressed at similar levels and the expression level of
cyt-353 scFv remains constant when increasing amount of HP1α, β
and γ plasmids are co-transfected (Fig. S1, Supplementary
material).
We then investigated whether LBR overexpression could rescue
the nuclear phenotype observed in cyt-353 scFv transfected cells.
We reasoned that Flag-LBR could stabilise the peripheral organi-
sation of heterochromatin at the nuclear envelope, making it
harder for the cyt-353 scFv to destabilise the structure. As shown
in the histogram of Fig. 6C, recombinant LBR is not able to restore
the 353-scFv-induced phenotype.
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Fig. 5. Co-sequestration of HP1β, LBR and H3:H4 core histones in 353 scFv cytoplasmic aggregates. (A) Western blot analysis of soluble (lanes 1 and 3) and insoluble (lanes
2 and 4) proteins extracted from nuclei (Nuc) and cytoplasm (Cyt) of non transfected NIH 3T3 cells. (B) Western blot analysis of insoluble pool derived from nuclei (Nuc) and
cytoplasm (Cyt) of non transfected (nt, lanes 1 and 2), cells transfected with αD11 scFv (lanes 3 and 4) and cyt-353 scFv intrabodies (lanes 5 and 6). (C) Western blot analysis
of insoluble pools extracted from nuclei (Nuc) and cytoplasm (Cyt) of NIH 3T3 cells transfected with the cyt-353 scFv fragment and cultured in the presence of 1 mM (lanes
2 and 5) and 5 mM Na butyrate (lanes 3 and 6) for 16 h. Detection of blots in A and B was performed by using speciﬁc antibodies for HP1β, LBR, Suvar39h1, histones H3, H4,
H2A and Me9H3. Blot in C was detected using rabbit anti-H3 IgG. Equivalent amount of soluble and insoluble proteins was loaded for each lane. The blots shown are
representative of three different experiments.
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In control experiments, co-expression of the control R4 scFv
(Fig. 6C) or αD11 (not shown) with increasing amount of re-
combinant HP1α, HP1γ or LBR does not cause an overt nuclear
alteration. As monitored by Western blot, recombinant HP1α, β, γ
and LBR are expressed at similar levels in these experimental
conditions (not shown).
In order to deﬁne the region of HP1β responsible for the rescue
of nuclear damages, we examined the contribution of the
N-terminal domain CD, the C-terminal CSD and the hinge region of
HP1β protein. To this aim, NIH 3T3 cells were co-transfected with
increasing amounts of GFP-tagged HP1β mutants that contain the
CSD (GFP-CSD), the CD (GFP-CD) or the hinge region (GFP-HP1h)
and with a constant amount of cyt-353 scFv (ratios HP1 mutants/
scFv1:4; 1:2; 1:1). As shown in Fig. 6D, the percentage of cells with
altered nuclear morphology/apoptotic phenotype decreases in a
dose dependant way only when cells are co-transfected with the
GFP-CSD mutant, the C-terminal portion of HP1β that contains the
epitope recognised by the cyt-353 intrabody (apoptosis/altered
nuclear morphology was reduced from 50% to 18–20%). On the
contrary, the GFP-CD and GFP-HP1h mutants do not have any ef-
fect on the phenotype of cyt-353 scFv transfected cells. In control
experiments, GFP-tagged HP1β mutants are expressed at similar
levels as veriﬁed by Western blot analysis (not shown). Altogether
these results conﬁrm that, in cells, the cyt-353 scFv intrabody
binds to the CSD of HP1β and maintains its immunospeciﬁcity and
that this speciﬁc interaction brings to the accumulation of ag-
gregates containing HP1β, LBR and H3/H4 histones in the cyto-
plasm with the concomitant effects on nuclear morphology and
cell viability.
3.5. Overexpression of HP1β-CD mutant displaces LBR from cyto-
plasmic HP1β-LBR aggregates
We next wanted to deﬁne the domain of HP1β that is involved
in the formation of cytoplasmic aggregates containing H3–H4 and
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Fig. 6. Rescue of the nuclear morphology and apoptotic phenotype by recombinant HP1β or CSD mutant. (A) NIH 3T3 cells were transiently transfected with cyt-353 scFv
fragment. Intrabody localisation was determined using anti-Myc antibodies (panels B and E). Panels A and D show the same cells counterstained with Hoechst 33342. Panels
C and F represent the merged images. Bar, 5 μm. (B) Nuclei with altered morphology and apoptotic cells (visualised either with Annexin V and with Hoechst 33342) of
intrabody transfected cells were counted. A dose-dependant effect of intrabody expression (0.5–2 μg DNA plasmid) was analysed. (C) NIH 3T3 ﬁbroblasts were co-transfected
with constant amount of cyt-353 fragment and increasing concentrations of recombinant Flag-tagged HP1s and Flag-tagged LBR constructs to assess the percentage of cells
with altered nuclei/apoptotic phenotype. As control we used R4 scFv intrabody. (D) NIH 3T3 were co-transfected with cyt-353 and GFP-HP1βmutants (CD, Hinge and CSD) to
evaluate the percentage of cells with altered nuclear morphology and apoptotic phenotype. At least 150 positively co-transfected cells for each plasmids were analysed. The
results shown are the average of three different experiments.
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LBR. To that end, we performed competition assays. In these ex-
periments a ﬁxed amount of cyt-353 scFv DNA plasmid was co-
transfected with increasing concentration of DNA encoding the
GFP tagged HP1β-CSD, HP1β-CD and HP1β-hinge (h) mutants
(ratios HP1 mutants/scFv1:4; 1:2; 1:1). By Western blot we ex-
amined the presence of HP1β, LBR and histones H3 and H4 in the
cytoplasmic insoluble fraction (Fig. 7A). Overexpression of the
C-terminal domain of HP1β (GFP-CSD) leads to the complete dis-
placement of HP1β, histones H3 and H4, and LBR proteins (Fig. 7A,
lane 4), conﬁrming that the CSD mutant competes with the
binding site of the cyt-353 scFv, thus abolishing the intrabody-
mediated formation of the cytoplasmic aggregates containing LBR
and H3/H4 histones. The GFP-CD mutant, on the contrary, does not
displace HP1β, but does compete with LBR for binding to HP1β
(Fig. 7A, lane 2). Histone H3 and H4 binding is affected, albeit only
slightly, by the expression of the GFP-CD mutant; there is ap-
proximately 20% decrease of the intensity of H3 and H4 bands in
the blots (Fig. 7A, lane 2). By contrast, co-transfection of the GFP-
HP1-hinge does not affect the aggregated HP1β, LBR and H3/H4
histones that remain in the insoluble cytoplasmic fraction (Fig. 7A,
lane 3).
The effect of increasing concentrations of the GFP-CD mutant
on the binding between LBR and HP1β was also veriﬁed and is
shown in Fig. 7B. We performed densitometric analysis to quantify
LBR in cytoplamic aggregates and found that a ratio of 1:1 be-
tween cyt-353 scFv and GFP-CD plasmids (6 μg:6 μg) reduces the
LBR band of 7875%. These data conﬁrmed that the CD mutant
inhibits LBR binding in a dose dependant fashion.
4. Discussion
Here we report that anti-HP1β intrabodies targeted to the cy-
toplasm of mammalian cells inhibit the trafﬁc of HP1β to the
nucleus and, consequently, its function. The intracellular expres-
sion of cyt-353 intrabody causes the intrabody-mediated seques-
tration of HP1β in the cytoplasm, where it often accumulates
around the external part of the nuclear envelope. Biochemical
analysis of cyt-353 scFv transfected cells indicates that the intra-
body-HP1β complex is present as intracellular cytoplasmic ag-
gregates. Since cyt-353 scFv is totally recovered in the cytoplasm
as insoluble aggregates, we hypothesise that the HP1β intrabody
interaction occurs in the cytoplasm and that the aggregation
promotes the sequestration of newly-synthetised HP1β in large
aggregates, physically impairing HP1β trafﬁc to the nucleus. Con-
sistent with this result the nuclear version of 353scFv also tends to
aggregate and localizes in the cytoplasmic compartment of
transfected cells, despite the presence of a dominant NLS signal,
leading to co-aggregation of HP1β in the cytoplasm (data not
shown). As reported for other intrabodies, the intrinsic insolubility
of cyt-353 scFv in the cytoplasm might be related to its net overall
charge and/or hydropathicity [50]. Control experiments showing
that another insoluble scFv does not lead to HP1β aggregation
suggest that even though the intrabody folding kinetics are sub-
optimal, there is still enough of a binding site present that the
effect appears to be speciﬁc, although direct evidence of this
mechanism is still lacking.
Biochemical and immunoﬂuorescence analysis of cyt-353 in-
trabody-transfected cells reveals that LBR and two core histones
(H3/H4) are also speciﬁcally sequestered in the cytoplasm, to-
gether with HP1β. The N-terminal portion of LBR is probably re-
sponsible for the binding to HP1β [26–28]. This domain is in an
open conformation free to interact with molecules in the mitotic
cytoplasm during nuclear reassembly. Competition experiments
with various HP1β mutants has allowed mapping of the LBR-
binding site within the N-terminal region of HP1β, which includes
the chromodomain. Thus, we ﬁnd a total displacement of LBR
when HP1-CD mutant is overexpressed. This is in accordance with
in vivo studies on the dynamic association between HP1 proteins
and elements of the nuclear membrane that have provided evi-
dence for a speciﬁc association of the CD region of HP1 with the
nuclear membrane [29] and, more speciﬁcally, with LBR through
H3/H4 histones [30,31]. We suspect that most of the LBR mole-
cules directly interact with the CD of HP1β rather than indirectly
through H3/H4 histones because overexpression of HP1β CD mu-
tant results in only 20% displacement of H3/H4. The interaction of
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Fig. 7. LBR interacts with the CD region of HP1β. (A) NIH 3T3 ﬁbroblasts were co-transfected with DNA plasmids encoding for cyt-353 scFv fragment (lane 1) or cyt-353 scFv
and GFP-CD (lane 2), GFP-HP1β hinge (lane 3) and GFP-CSD (lane 4) mutants. Western blot of insoluble cytoplasmic proteins was performed by using speciﬁc antibodies for
HP1β, LBR, histones H3 and H4. Equal amount of proteins was loaded for each lane. (B) Western blot analysis of insoluble cytoplasmic proteins derived from cells transfected
with cyt-353 scFv (lane 1) or cyt-353 scFv and increasing concentrations of DNA plasmid encoding for GFP–CD mutant (lanes 2–4) using rabbit anti-LBR antibodies (upper
panel). Lower panel shows the densitometric quantitation of LBR immunoreactive band in the cytoplasmic insoluble fraction. 100% refers to the amount of LBR in cytoplasmic
aggregates of cyt-353 scFv transfected cells. The results shown are representative of three different experiments.
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HP1β with H3/H4 histones may take place via the H3:CSD dimer
interaction, as described for HP1α and γ [51].
Notwithstanding the fact that histones H3/H4 are diverted to
the cytoplasm in 353-scFv expressing cells, the intracellular dis-
tribution of Me9H3 and its speciﬁc methyltransferase Suvar39h1 is
not affected. We propose two different explanations for this result.
First, since methylation of H3 occurs in the nucleus [52], cyt-353
intrabody is not able to intercept methylated pool of H3 (i.e.
Me9H3) bound to HP1β, but may interact only with the neo-
synthetised and unmethylated H3 molecules. Of note, Dialynas
et al. demonstrated that HP1β is able to directly interact with H3,
regardless of its methylation state [31]. A second possibility is that
the methylated pool of H3 interacting with HP1β might form part
of the small, very-slow immobile HP1β fraction already in-
corporated in the heterochromatin, thus not accessible to the in-
teraction with cyt-353 intrabody even during mitosis [53].
Treatment of cyt-353 scFv expressing cells with histone dea-
cetylase inhibitors TSA or sodium butyrate impairs the seques-
tration of H3/H4 in cytoplasmic aggregates in a dose dependant
manner. The most likely explanation is that histone deacetylase
(HDAC) inhibitors disrupt the interaction of histones with HP1
proteins that are incorporated into the cytoplasmic aggregates by
the intrabody and thereby lead to the dispersion of the histones.
This is consistent with previous work which has shown that his-
tone:HP1 interaction is disrupted by HDAC inhibitors [54]. How-
ever, it is also possible that the neutralization of charge that results
from deacetylation may also inﬂuence the incorporation of the
histones into the intrabody aggregates.
In cyt-353 scFv transfected cells, most nuclei have irregular
shape with lobules and deep invaginations of the envelope and a
high percentage of cells undergo apoptosis. Our observation that
ablation of HP1β induces altered nuclear morphology supports a
role for HP1β in maintaining the nuclear lamina reassembly [55].
In particular, HP1-NE associations regulate the NE reassembly at
the end of mitosis [29] and LBR and H3–H4 histones are involved
in this function [30,31].
Overexpression of recombinant full-length HP1β or C-terminal
(CSD) fragment of HP1β, which represents the intrabody-binding
site, abolishes the formation of intracellular cytoplasmic ag-
gregates, rescues the altered nuclear morphology and protects
from apoptosis. Interestingly, a moderate rescue of these pheno-
types is obtained by overexpression of recombinant HP1α, but
only at highest concentration, suggesting a functional redundancy
between HP1β and HP1α [13]. In contrast, over-expressing re-
combinant LBR or HP1β-CD mutant, which displaces endogenous
LBR from cyt-353 scFv cytoplasmic complexes, does not rescue the
phenotype. Taken together, these ﬁndings raise the possibility that
an association involving components of condensed chromatin and
inner nuclear membrane proteins in the cytoplasm might provide
the basis for organising peripheral heterochromatin and regulating
nuclear envelope assembly. A future line of research will be to
investigate the relationship between the LBR/H3–H4/HP1β com-
plex and regulation of genome organisation and expression at the
nuclear periphery [56,57].
We describe two major phenotypes in cyt-353 intrabody ex-
pressing cells: an altered nuclear morphology and cell death. Si-
milar results were obtained with anti-chromodomain aggregating
intrabodies which are able to divert HP1β in aggregates, inducing
cell death phenotypes associated with pronounced invaginations
and lobules formation of the nuclear membrane [11]. In contrast,
intrabody-mediated diverting of Ras oncoprotein to cytoplasmic
aggregates induces apoptosis without altering nuclear morphol-
ogy [8]. These results, together with the present study, support the
notion that HP1β is important in maintaining nuclear membrane
integrity. Of note, in mandibuloacral dysplasia, a rare form of la-
minopathy due to a mutation in LMNA gene encoding lamin A/C,
the delocalisation of HP1β and LBR is associated to a marked al-
teration of nuclear membrane and chromatin organisation [58]. It
is not clear, however, whether HP1β is required for cell survival or
whether intrabody aggregation is responsible for cell death ob-
served in about 60% of transfected cells. Thus, although we ﬁnd
that intrabody-mediated HP1β aggregation in the cytoplasm in-
duces cell death, knockdown of HP1β by speciﬁc RNAi in different
cell types neither induces cell death nor alters cell cycle progres-
sion [37,38]. Moreover, mice expressing only 10% of HP1β protein
levels are indistinguishable from wild-type littermates [35] and
displacement of HP1β from constitutive heterochromatin by using
dominant negative HP1 constructs does not affect cell viability,
suggesting that the amount of HP1β required for survival is small
[59,53].
We envisage different explanations for the cell death pheno-
type observed in cyt-353 scFv expressing cells. One possibility is
that intrabody-mediated aggregation of HP1β, a well-known
adaptor protein able to recruit several binding partners, leads to
knockdown of these proteins, including LBR and H3/H4 histones,
which could be required for cell survival. Alternatively, cell death
may result from the formation of cytoplasmic inclusions, which
derive from abnormal accumulation and aggregation of proteins
prone to misfold observed in different pathological conditions,
including neurodegenerative diseases and cancer [60,61]. Accord-
ingly, intrabodies may act as amyloid-like proteins promoting,
beyond the described speciﬁc interactions, widespread aberrant
interactions with other unrelated proteins having essential cellular
functions, leading to cell toxicity [62], or intrabody-mediated cy-
toplasmic HP1β aggregation could induce an apoptotic phenotype
strictly related to the impairment of proteasome activity, as we
have previously reported for anti-Ras intrabodies [8,63]. Regarding
the latter, it has been recently shown that aggregation of proteins
such as Tau, α-synuclein and p53, also termed as intrinsically
disordered proteins (IDPs), is able to trigger a cytotoxic response
associated with proteasome inhibition. IDPs may also promote
aberrant interactions with other proteins, leading to diversion
from their functional sites and sequestration into aggregates,
thereby enhancing their cytotoxic potential [64,65]. In this context,
aggregating intrabodies such as 353-anti-HP1β, anti-CD, anti-Ras
and anti-E6 viral protein [8,11,66] could act as IDPs, inducing cell
death through co-aggregation and accumulation of crucial pro-
teins and consequent engulfment of the ubiquitin–proteasomal
system. The property of intrabodies to speciﬁcally interfere with
the aggregation kinetics and on modulating the severity of cellular
dysfunction could be further exploited in therapy of pathological
conditions where it is necessary to induce cell death, such as, for
example, in tumours.
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